Yes Doc did indeed say that. Thanks for reminding

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

i3 Verticals' Strategic Transformation Enhances Market Position i3 Verticals (NASDAQ: IIIV), recognized for providing integrated payment and software solutions, has recently received a boost in market confidence following the announcement of its significant $438 million divestiture. This strategic decision marks a pivotal moment for the company, allowing it to sharpen its...

Exploring the Benefits of Placental Allografts Marietta, GA – MiMedx Group, Inc. (NASDAQ: MDXG) has recently spotlighted the insights shared in a feature article about placental allografts, which focus on their application for healing complex wounds. This discussion surfaced through a compelling article in a major publication, highlighting the incredible advantages...

Crimson Cup Supports Anniversaries of 13 Independent Coffee Shops Crimson Cup Coffee & Tea is proud to acknowledge the special anniversaries of 13 independent coffee houses this month. These remarkable shops are located in various states and have embraced their milestones, ranging from one year to an impressive 13 years of serving delicious coffee. The success these...

Insights on UK Economic Trends for 2025 The new year has arrived, and Deutsche Bank (ETR: DBKGn) has highlighted eight vital themes expected to influence the UK economy as we move further into 2025. Despite current uncertainties, analysts from Deutsche Bank express a level of optimism, indicating that government spending is likely to become a significant contributor to...

Centene Corporation's Stellar 2024 Financial Overview Centene Corporation (NYSE: CNC) showcased robust financial performance for the year 2024, highlighted by a significant increase in diluted earnings per share (EPS) and revenue growth across various segments. The company's diluted EPS rose to $6.31, with an adjusted diluted EPS reaching $7.17, reflecting a 7% increase...